Richard William Scalzo - 14 Mar 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Senior Vice President, Head of Finance and Administration
Signature
/s/ Richard Scalzo
Issuer symbol
DYN
Transactions as of
14 Mar 2023
Net transactions value
-$17,476
Form type
4
Filing time
15 Mar 2023, 17:51:13 UTC
Previous filing
13 Dec 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Sale $17,476 -1,311 -2.3% $13.33 54,872 14 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 10, 2021 and December 9, 2022. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
F2 Includes 46,277 unvested RSUs.

Remarks:

Senior Vice President, Head of Finance and Administration